Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
TRK inhibitors
1 evidence topic · 1 source
Bezuclastinib
Gastrointestinal stromal tumor
- Manufacturer
- Cogent Biosciences
- Regulatory submission
- NDA submitted April 2026
- Last updated